HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jiae Koh Selected Research

Jiae Koh Research Topics

Disease

9Neoplasms (Cancer)
10/2021 - 10/2012
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2020 - 01/2016
1Lung Neoplasms (Lung Cancer)
10/2021
1Thymic epithelial tumor
01/2020
1Retinoblastoma (Glioblastoma, Retinal)
03/2016
1Squamous Cell Carcinoma of Head and Neck
03/2016
1Acne Vulgaris
01/2016
1Diarrhea
01/2016
1Exanthema (Rash)
01/2016
1Fatigue
01/2016
1Neutropenia
01/2016
1Ovarian Neoplasms (Ovarian Cancer)
10/2012
1Neoplasm Metastasis (Metastasis)
10/2012

Drug/Important Bio-Agent (IBA)

2Immune Checkpoint InhibitorsIBA
10/2021 - 11/2020
2NivolumabIBA
01/2020 - 01/2019
2pembrolizumabIBA
01/2020 - 01/2019
1Cancer VaccinesIBA
10/2021
1Interleukin-15 (Interleukin 15)IBA
01/2021
1Programmed Cell Death 1 ReceptorIBA
01/2019
1Biomarkers (Surrogate Marker)IBA
01/2019
1adavosertibIBA
09/2017
1Phosphotransferases (Kinase)IBA
09/2017
1DNA (Deoxyribonucleic Acid)IBA
09/2017
1Cyclin-Dependent Kinases (cdk Proteins)IBA
03/2016
1abemaciclibIBA
03/2016
1Cyclin D1IBA
03/2016
1ErbB Receptors (EGF Receptor)IBA
01/2016
1osimertinibIBA
01/2016
1nimotuzumabIBA
01/2016
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2016
1Gefitinib (Iressa)FDA Link
01/2016
1AfatinibIBA
01/2016
1Proteins (Proteins, Gene)FDA Link
01/2016
1Histocompatibility Antigens Class IIBA
10/2012
1LigandsIBA
10/2012
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2012
1Cisplatin (Platino)FDA LinkGeneric
10/2012
1Antineoplastic Agents (Antineoplastics)IBA
10/2012

Therapy/Procedure

2Therapeutics
12/2020 - 01/2019
2Aftercare (After-Treatment)
12/2020 - 01/2019
2Immunotherapy
11/2020 - 10/2012
1Oral Administration
01/2016